-
student-scholarship holder at the Poznan Doctoral School of Institutes of Polish Academy of Sciences
of cancer cells to treatment is hypoxia in the tumor microenvironment. This phenomenon affects approximately 50–80% of patients with stage I–IV NSCLC and is a recognized poor prognostic factor. Despite
Searches related to component labeling
Enter an email to receive alerts for component-labeling positions